1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Botensilimab (AGEN1181) for the Treatment of Advanced MelanomaAdvanced MelanomaActive, not recruitingPhase 22026-01-16NCT05529316